Pharmac looks to fund IOs for NSCLC

By Megan Brodie 1 year ago | In New Zealand
  • 1 year ago
Pharmac CEO Sarah Fitt

16 December 2022 New Zealand has revealed it is looking to fund MSD’s KEYTRUDA (pembrolizumab)…

This is subscriber-only content. Please login to continue reading.